vs
HECLA MINING CO（HL）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是HECLA MINING CO的1.4倍（$622.0M vs $448.1M），Royalty Pharma plc净利率更高（34.4% vs 30.0%，领先4.4%），HECLA MINING CO同比增速更快（79.5% vs 4.8%），过去两年HECLA MINING CO的营收复合增速更高（53.8% vs 4.6%）
赫克拉矿业是总部位于美国的金属开采企业，主营银、金、铅、锌等矿产开发，矿区主要分布于北美地区，产品供应珠宝、工业制造、新能源供应链等领域，是美国头部原生银生产商之一。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
HL vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.4倍
$448.1M
营收增速更快
HL
高出74.7%
4.8%
净利率更高
RPRX
高出4.4%
30.0%
两年增速更快
HL
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $448.1M | $622.0M |
| 净利润 | $134.4M | $214.2M |
| 毛利率 | 55.4% | — |
| 营业利润率 | 49.1% | 62.4% |
| 净利率 | 30.0% | 34.4% |
| 营收同比 | 79.5% | 4.8% |
| 净利润同比 | 1027.2% | 2.9% |
| 每股收益（稀释后） | $0.20 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HLRPRX
| Q4 25 | $448.1M | $622.0M | ||
| Q3 25 | $409.5M | $609.3M | ||
| Q2 25 | $304.0M | $578.7M | ||
| Q1 25 | $261.3M | $568.2M | ||
| Q4 24 | $249.7M | $593.6M | ||
| Q3 24 | $245.1M | $564.7M | ||
| Q2 24 | $245.7M | $537.3M | ||
| Q1 24 | $189.5M | $568.0M |
净利润HLRPRX
| Q4 25 | $134.4M | $214.2M | ||
| Q3 25 | $100.7M | $288.2M | ||
| Q2 25 | $57.7M | $30.2M | ||
| Q1 25 | $28.9M | $238.3M | ||
| Q4 24 | $11.9M | $208.2M | ||
| Q3 24 | $1.8M | $544.0M | ||
| Q2 24 | $27.9M | $102.0M | ||
| Q1 24 | $-5.8M | $4.8M |
毛利率HLRPRX
| Q4 25 | 55.4% | — | ||
| Q3 25 | 44.1% | — | ||
| Q2 25 | 39.3% | — | ||
| Q1 25 | 28.3% | — | ||
| Q4 24 | 27.4% | — | ||
| Q3 24 | 24.2% | — | ||
| Q2 24 | 20.9% | — | ||
| Q1 24 | 10.1% | — |
营业利润率HLRPRX
| Q4 25 | 49.1% | 62.4% | ||
| Q3 25 | 36.3% | 70.1% | ||
| Q2 25 | 30.8% | 36.3% | ||
| Q1 25 | 20.0% | 94.0% | ||
| Q4 24 | 15.3% | 60.9% | ||
| Q3 24 | 9.2% | — | ||
| Q2 24 | 16.5% | 50.2% | ||
| Q1 24 | 2.7% | -13.0% |
净利率HLRPRX
| Q4 25 | 30.0% | 34.4% | ||
| Q3 25 | 24.6% | 47.3% | ||
| Q2 25 | 19.0% | 5.2% | ||
| Q1 25 | 11.0% | 41.9% | ||
| Q4 24 | 4.8% | 35.1% | ||
| Q3 24 | 0.7% | 96.3% | ||
| Q2 24 | 11.3% | 19.0% | ||
| Q1 24 | -3.0% | 0.8% |
每股收益（稀释后）HLRPRX
| Q4 25 | $0.20 | $0.49 | ||
| Q3 25 | $0.15 | $0.67 | ||
| Q2 25 | $0.09 | $0.07 | ||
| Q1 25 | $0.05 | $0.55 | ||
| Q4 24 | $0.03 | $0.46 | ||
| Q3 24 | $0.00 | $1.21 | ||
| Q2 24 | $0.04 | $0.23 | ||
| Q1 24 | $-0.01 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $301.2M | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $2.6B | $9.7B |
| 总资产 | $3.6B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资HLRPRX
| Q4 25 | $301.2M | $618.7M | ||
| Q3 25 | $133.9M | $938.9M | ||
| Q2 25 | $296.6M | $631.9M | ||
| Q1 25 | $23.7M | $1.1B | ||
| Q4 24 | $26.9M | $929.0M | ||
| Q3 24 | $22.3M | $950.1M | ||
| Q2 24 | $24.6M | $1.8B | ||
| Q1 24 | $80.2M | $843.0M |
总债务HLRPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益HLRPRX
| Q4 25 | $2.6B | $9.7B | ||
| Q3 25 | $2.4B | $9.6B | ||
| Q2 25 | $2.3B | $9.5B | ||
| Q1 25 | $2.1B | $9.8B | ||
| Q4 24 | $2.0B | $10.3B | ||
| Q3 24 | $2.0B | $10.3B | ||
| Q2 24 | $2.0B | $9.8B | ||
| Q1 24 | $2.0B | $9.9B |
总资产HLRPRX
| Q4 25 | $3.6B | $19.6B | ||
| Q3 25 | $3.2B | $19.3B | ||
| Q2 25 | $3.3B | $18.3B | ||
| Q1 25 | $3.0B | $17.6B | ||
| Q4 24 | $3.0B | $18.2B | ||
| Q3 24 | $3.0B | $18.0B | ||
| Q2 24 | $2.9B | $17.7B | ||
| Q1 24 | $3.0B | $16.1B |
负债/权益比HLRPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $217.1M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $134.7M | — |
| 自由现金流率自由现金流/营收 | 30.1% | — |
| 资本支出强度资本支出/营收 | 18.4% | — |
| 现金转化率经营现金流/净利润 | 1.61× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $310.2M | — |
8季度趋势，按日历期对齐
经营现金流HLRPRX
| Q4 25 | $217.1M | $827.1M | ||
| Q3 25 | $148.0M | $702.6M | ||
| Q2 25 | $161.8M | $364.0M | ||
| Q1 25 | $35.7M | $596.1M | ||
| Q4 24 | $67.5M | $742.5M | ||
| Q3 24 | $55.0M | $703.6M | ||
| Q2 24 | $78.7M | $658.2M | ||
| Q1 24 | $17.1M | $664.6M |
自由现金流HLRPRX
| Q4 25 | $134.7M | — | ||
| Q3 25 | $90.1M | — | ||
| Q2 25 | $103.8M | — | ||
| Q1 25 | $-18.4M | — | ||
| Q4 24 | $6.7M | — | ||
| Q3 24 | $-690.0K | — | ||
| Q2 24 | $28.3M | — | ||
| Q1 24 | $-30.5M | — |
自由现金流率HLRPRX
| Q4 25 | 30.1% | — | ||
| Q3 25 | 22.0% | — | ||
| Q2 25 | 34.1% | — | ||
| Q1 25 | -7.0% | — | ||
| Q4 24 | 2.7% | — | ||
| Q3 24 | -0.3% | — | ||
| Q2 24 | 11.5% | — | ||
| Q1 24 | -16.1% | — |
资本支出强度HLRPRX
| Q4 25 | 18.4% | — | ||
| Q3 25 | 14.1% | — | ||
| Q2 25 | 19.1% | — | ||
| Q1 25 | 20.7% | — | ||
| Q4 24 | 24.3% | — | ||
| Q3 24 | 22.7% | — | ||
| Q2 24 | 20.5% | — | ||
| Q1 24 | 25.1% | — |
现金转化率HLRPRX
| Q4 25 | 1.61× | 3.86× | ||
| Q3 25 | 1.47× | 2.44× | ||
| Q2 25 | 2.80× | 12.06× | ||
| Q1 25 | 1.24× | 2.50× | ||
| Q4 24 | 5.66× | 3.57× | ||
| Q3 24 | 31.24× | 1.29× | ||
| Q2 24 | 2.82× | 6.45× | ||
| Q1 24 | — | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HL
| Silver Contracts | $258.5M | 58% |
| Gold | $129.2M | 29% |
| Zinc | $30.3M | 7% |
| Lead | $23.3M | 5% |
| Environmental Remediation Services | $9.2M | 2% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
